Atyr Pharma Inc (LIFE)

Finanzdaten der Atyr Pharma Inc-Aktie (LIFE)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	0.353	-	-	10.39
Operating Expenses	23.06% 15.96	12.97	13.56	12.79	18.34
Benefits Costs and Expenses	26.20% 14.76	11.70	-	-	-
Costs And Expenses	26.20% 14.76	11.70	-	-	-
Operating Income/Loss	26.51% -15.96	-12.62	-13.56	-12.79	-7.95
Nonoperating Income/Loss	5.89% 1.198	1.273	1.216	0.835	0.427
Income/Loss From Continuing Operations Before Tax	30.13% -14.76	-11.34	-12.34	-11.95	-7.52
Income/Loss From Continuing Operations After Tax	30.13% -14.76	-11.34	-12.34	-11.95	-7.52
Net Income/Loss	30.14% -14.76	-11.34	-12.34	-11.95	-7.523
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	50.00% -0.001	-0.002	-0.004	-0.001	-0.002
Basic Average Shares	96.71% 1.9056	57.89	55.14	41.90	0.2349
Diluted Average Shares	96.71% 1.9056	57.89	55.14	41.90	0.2349
Basic Earnings Per Share	25.00% -0.25	-0.20	-0.22	-0.29	-0.26
Diluted Earnings Per Share	25.00% -0.25	-0.20	-0.22	-0.29	-0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-